Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex healthcare environment. 2. In-depth interviews with 80 key informants (65 interviews) explored and compared factors in terms of barriers and enablers to reclassification of medicines in each country. However, Rx-to-OTC switches today primarily occur through the NDA procedures. The EU as well as China and other countries have expanded the OTC use of products that were once available only via prescription, expanding the market potential even more. Each of these tactics has been successful for various brands over the years.

A dedicated product manager to monitor all social media is important. With the OTC switch, these audiences should be informed of the impending OTC availability of the product. Consumers often assume safety and efficacy because the product is approved by the government. He is currently consulting with MIP Corporation to help implement the new paradigm methodology in marketing and sales departments.In today’s economy, all of us are at risk for serious information overload. However, many FDA-approved OTC drug products (i.e., OTC products that have an approved NDA) begin their lifecycle as NDA-approved prescription drugs, and then eventually switch to OTC status under the NDA provisions. These changes raise the question whether the current innovation and product-oriented business model is the right one to face future challenges. The endpoints of consumer studies would need to demonstrate that a nonprescription version can be adequately labeled such that “The consumer can self-diagnose, self-treat, and self-manage the condition being treated. The research purpose based on derived evaluation criteria for the constitution of pharmaceutical brand architecture is affiliated. Physicians should be informed of any differences between the prescription product and the OTC version (i.e., strength, dosing, etc.). • Consumers increased their information search efforts using professional sources for prescription drugs when they feel higher levels of threat from diseases.The pharmaceutical industry is confronted with high competition, decreasing growth rates and a lower number of new ingredients. Non-prescription sales of oseltamivir were slow during this period.

Many well- known brands are ripe for repurposing. He is currently a director of Evidence Based Marketing, aspecialised business planning consultancy, based in the UK.had moved OTC in America, along with 0.5 per cent hydrocortisone) and several cold remedies. Consequently, to maximize the chance for success, these media must be managed for the OTC switch.

and 4) What are the internal marketing challenges and how to address them?Experience has shown that some product classes are more readily accepted for Rx-to-OTC switching by the FDA. Initially, physicians must be convinced of the efficacy and safety of the product versus other competitors in the class. 28-06-2017. The Rx-to-OTC switch process has a positive impact on the U.S. healthcare system process by driving down overall healthcare costs. Many pharmacists adopted a 'risk-benefit analysis' that balanced symptom severity with perceived value for money. The introduction of By contrast, H2 receptor antagonists entered the unsatisfied GERD/heartburn market as an alternative to antacids. Yet once an active ingredient is so designated, scores of products may emerge from it, including one or more bearing the original brand, private labels, and combination products. However, many FDA-approved OTC drug products (i.e., OTC products that have an approved NDA) begin their lifecycle as NDA-approved prescription drugs, and then eventually switch to OTC status under the NDA provisions.